Braun Stacey Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.4M | Buy |
+170,370
| New | +$21.4M | 0.77% | 58 |
|
|
2019
Q3 | – | Sell |
-2,379
| Closed | -$201K | – | 121 |
|
|
2019
Q2 | $201K | Sell |
2,379
-74,148
| -97% | -$6.26M | 0.01% | 114 |
|
|
2019
Q1 | $6.74M | Sell |
76,527
-30,410
| -28% | -$2.68M | 0.45% | 93 |
|
|
2018
Q4 | $7.64M | Sell |
106,937
-45,637
| -30% | -$3.26M | 0.61% | 83 |
|
|
2018
Q3 | $18.8M | Buy |
152,574
+6,680
| +5% | +$821K | 1.2% | 22 |
|
|
2018
Q2 | $14.3M | Buy |
+145,894
| New | +$14.3M | 0.97% | 45 |
|